Impaired Kidney Graft Survival is Associated with the TNF-α Genotype
- 15 July 2004
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 78 (1), 117-121
- https://doi.org/10.1097/01.tp.0000134768.82277.cb
Abstract
The TNF2 allele at position -308 of the tumor necrosis factor (TNF)-alpha gene is associated with high TNF production. The purpose was to study the association of this gene polymorphism with rejection episodes and graft survival after kidney transplantation. A retrospective analysis of transplant outcomes of patients who only had been treated with one single form of immunosuppression consisting of cyclosporine, azathioprine, and prednisolon was performed. We found that 115 (73%) patients had the TNF1/TNF1 genotype, whereas 42 (27%) were TNF2 positive. There was no difference in the overall acute rejection frequency between these two groups (50% in each), but our data showed a non-significant tendency towards a higher frequency of steroid resistant rejections in the TNF2 positive group (57% vs. 40%). There was no significant difference in graft survival between the two genotype groups, although an early tendency towards worse survival was seen in TNF2 recipients. However, the TNF2 positive recipients with rejection episodes had far worse graft survival compared with the TNF1/TNF1 recipients with rejection episodes (P<0.02). No difference was seen between the two genotype groups in patients without rejection episodes. Our data propose that potentially high TNF producers with the TNF2 allele do not have an increased risk for rejection episodes, but if rejection episodes occur, they have a significantly increased risk for early graft loss. TNF production may intensify rejection, but is not a primary factor for the induction of such acute immune activation.This publication has 22 references indexed in Scilit:
- Gene polymorphisms and transplantationCurrent Opinion in Immunology, 2001
- A study of cytokine gene polymorphisms and protein secretion in renal transplantationTransplant Immunology, 2001
- TNF-? gene polymorphism: Clinical and biological implicationsMicroscopy Research and Technique, 2000
- The −308 tumor necrosis factor-α promoter polymorphism effects transcriptionMolecular Immunology, 1997
- Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activationProceedings of the National Academy of Sciences of the United States of America, 1997
- Secretion of Tumour Necrosis Factor α and Lymphotoxin α in Relation to Polymorphisms in the TNF Genes and HLA‐DR Alleles. Relevance for Inflammatory Bowel DiseaseScandinavian Journal of Immunology, 1996
- PLASMA LEVELS OF TUMOR NECROSIS FACTOR (TNF) AND SOLUBLE TNF RECEPTORS IN KIDNEY TRANSPLANT RECIPIENTSTransplantation, 1994
- THE IMPACT OF ACUTE REJECTION EPISODES ON LONG-TERM GRAFT FUNCTION AND OUTCOME IN 1347 PRIMARY RENAL TRANSPLANTS TREATED BY 3 CYCLOSPORINE REGIMENSTransplantation, 1993
- EVALUATION OF SEQUENTIAL PLASMA AND URINARY TUMOR NECROSIS FACTOR ALPHA LEVELS IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1991
- Effects of tumor necrosis factor on the interferon‐γ‐induced major histocompatibility complex class II antigen expression by human endothelial cellsEuropean Journal of Immunology, 1988